Pizzolo G - Search Results

1

ICAM-1 tissue overexpression associated with increased serum levels of its soluble form in Hodgkin's disease.

Pizzolo G, Vinante F, Nadali G, Ricetti MM, Morosato L, Marrocchella R, Vincenzi C, Semenzato G, Chilosi M. Pizzolo G, et al. Br J Haematol. 1993 May;84(1):161-2. doi: 10.1111/j.1365-2141.1993.tb03040.x. Br J Haematol. 1993. PMID: 8101721

2

Correlation between clinical features and circulating levels of soluble intercellular adhesion molecule-1 in Hodgkin's disease.

Nadali G, Vinante F, Rigo A, Tecchio C, Morosato L, Zanolin E, Perona G, Chilosi M, Pizzolo G. Nadali G, et al. Among authors: pizzolo g. Int J Clin Lab Res. 1995;25(2):84-7. doi: 10.1007/BF02592362. Int J Clin Lab Res. 1995. PMID: 7663010 Clinical Trial.

3

Biopathologic features of Hodgkin's disease.

Chilosi M, Pizzolo G. Chilosi M, et al. Among authors: pizzolo g. Leuk Lymphoma. 1995 Feb;16(5-6):385-95. doi: 10.3109/10428199509054424. Leuk Lymphoma. 1995. PMID: 7787748 Review.

4

Serum levels of soluble CD30 in chronic hepatitis B virus infection.

Fattovich G, Vinante F, Giustina G, Morosato L, Alberti A, Ruol A, Pizzolo G. Fattovich G, et al. Among authors: pizzolo g. Clin Exp Immunol. 1996 Jan;103(1):105-10. doi: 10.1046/j.1365-2249.1996.915607.x. Clin Exp Immunol. 1996. PMID: 8565268 Free PMC article.

5

Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disorders.

Vinante F, Vassanelli A, Zanotti R, Nadali G, Krampera M, Vincenzi C, Morosato L, Chilosi M, Pizzolo G. Vinante F, et al. Among authors: pizzolo g. Int J Clin Lab Res. 1995;25(4):189-94. doi: 10.1007/BF02592696. Int J Clin Lab Res. 1995. PMID: 8788546

6

High serum level of soluble CD30 in acute primary HIV-1 infection.

Pizzolo G, Vinante F, Nadali G, Krampera M, Morosato L, Chilosi M, Raiteri R, Sinicco A. Pizzolo G, et al. Clin Exp Immunol. 1997 May;108(2):251-3. doi: 10.1046/j.1365-2249.1997.d01-1005.x. Clin Exp Immunol. 1997. PMID: 9158093 Free PMC article.

7

Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome.

Nadali G, Tavecchia L, Zanolin E, Bonfante V, Viviani S, Camerini E, Musto P, Di Renzo N, Carotenuto M, Chilosi M, Krampera M, Pizzolo G. Nadali G, et al. Among authors: pizzolo g. Blood. 1998 Apr 15;91(8):3011-6. Blood. 1998. PMID: 9531614 Free article.

8

Soluble molecules as biological markers in Hodgkin's disease.

Nadali G, Vinante F, Chilosi M, Pizzolo G. Nadali G, et al. Among authors: pizzolo g. Leuk Lymphoma. 1997 Dec;26 Suppl 1:99-105. doi: 10.3109/10428199709058606. Leuk Lymphoma. 1997. PMID: 9570686

9

Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome.

Vinante F, Rigo A, Tecchio C, Morosato L, Nadali G, Ricetti MM, Krampera M, Zanolin E, Locatelli F, Gallati H, Chilosi M, Pizzolo G. Vinante F, et al. Among authors: pizzolo g. Br J Haematol. 1998 Sep;102(4):1025-34. doi: 10.1046/j.1365-2141.1998.00872.x. Br J Haematol. 1998. PMID: 9734654 Free article.

10

High serum levels of B-lymphocyte stimulator are associated with clinical-pathological features and outcome in classical Hodgkin lymphoma.

Tecchio C, Nadali G, Scapini P, Bonetto C, Visco C, Tamassia N, Vassilakopoulos TP, Pangalis GA, Calzetti F, Nardelli B, Roschke V, Gottardi M, Zampieri F, Gherlinzoni F, Facchetti F, Pizzolo G, Cassatella MA. Tecchio C, et al. Among authors: pizzolo g. Br J Haematol. 2007 Jun;137(6):553-9. doi: 10.1111/j.1365-2141.2007.06615.x. Br J Haematol. 2007. PMID: 17539776 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

328 results

Search Page

Filters